RCM
KLRS

RA Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

RA Capital Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-62,632
Closed -$9.72M – 102
2022
Q1 		$9.72M Buy
+62,632
New +$9.72M 0.21% 78